Plasma serotonin levels and the platelet serotonin transporter

Journal of Neurochemistry

Volumn 102, Issue 1, 2007, Pages 206-215

  Brenner, B ^a   Harney, J T ^a   Ahmed, B A ^a   Jeffus, B C ^a   Unal, R ^a   Mehta, J L ^a   Kilic, F ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Hypertension; Plasma serotonin level; Platelet serotonin uptake; Serotonin; Serotonin transporter

Indexed keywords

SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; CELL ISOLATION; CELL LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; HYPERTENSION; INTRACELLULAR TRANSPORT; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SEROTONIN BLOOD LEVEL; THROMBOCYTE; THROMBOCYTE MEMBRANE;

BIOTIN; BLOOD PLATELETS; BLOTTING, WESTERN; CELL MEMBRANE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEEDBACK; HUMANS; HYPERTENSION; KINETICS; MALE; MIDDLE AGED; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 34250167250     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04542.x     Document Type: Article

References (48)

1. Arora R. C. Meltzer H. Y. (1990) 3H-imipramine binding in the blood platelets of normal twins. Psychiatry Res. 32, 265 273.
2. Azzadin A., Mysliwiec J., Wollny T., Mysliwiec M. Buczko W. (1995) Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats. Thromb. Res. 77, 217 224.
3. Bengel D., Murphy D. L., Andrews A. M., Wichems C. H., Feltner D., Heils A., Mossner R., Westphal H. Lesch, K. (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol. Pharmacol. 53, 649 655.
4. Bernstein E. M. Quick M. W. (1999) Regulation of gamma-aminobutyric acid (GABA) transporters by exogenous GABA. J. Biol. Chem. 274, 889 895.
5. Blakely R. D., Berson H. E., Fremeau R. T., Jr. Caron M. C., Peek M. M. Priace H. K. Bradley C. C. (1991) Cloning and expression of a functional the 5HT transporter from rat brain. Nature 354, 66 70.
6. Blann A. D., Nadar S. Lip G. Y. (2003) Pharmacological modulation of platelet function in hypertension. Hypertension 42, 1 7.
7. Brass L. F. (1999) More pieces of the platelet activation puzzle slide into place. J. Clin. Invest. 104, 1663 1665.
8. Corash L., Costa J. L., Shafer B., Donlon J. A. Murphy D. L. (1984) Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood 64, 185 193.
9. Dabire H., Cherqui C., Fournier B. Schmitt H. (1987) Comparison of effects of some 5-HT1 agonists on blood pressure and heart rate of normotensive anaesthetized rats. Eur. J. Pharmacol. 140, 259 266.
10. Doggrell S. A. (2001) Pharmacotherapy of intermittent claudication. Expert Opin. Pharmacother. 2, 1725 1736
11. Duan S., Anderson C. M., Stein B. A. Swanson R. A. (1999) Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J. Neurosci. 19, 10193 10200.
12. Egan B., Conlon M. E., Campbell R., Schork N., Zwiefler A. Julius S. (1988) Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension. Am. J. Hypertens. 1, 324S 330S.
13. Freyburger W. A., Graham B. E., Rapport M. M., Seay P. H., Govier W. M., Swoap O. F. Vander Brook M. J. (1952) The pharmacology of 5-hydroxytryptamine (serotonin). J. Pharmacol. Exp. Ther. 105, 80 86.
14. Golino P., Piscione F., Willerson J. T., et al. (1991) Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. New Engl. J. Med. 324, 641 648.
15. Gujrati V. R., Goyal A., Gaur S. P., Singh N., Shanker K. Chandravati. (1994) Relevance of platelet serotonergic mechanisms in pregnancy induced hypertension. Life Sci. 55, 327 335.
16. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D. Lesch K. P. (1996) Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66, 2621 2624.
17. Hoffman B. J., Mezey E. Browstein M. J. (1991) Cloning of the 5HT transporter affected by antidepressants. Science 254, 579 580.
18. Jafri S. M., Chandra N., Dhawan S., Soni D., Chandra M. Shanker K. (1992) Factors influencing platelet serotonin uptake in essential hypertension. Int. J. Cardiol. 34, 327 333.
19. Johnson G. J., Leis L. A., Dunlop P. C. Weir E. K. (2003) The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux. J. Thromb. Haemost. 1, 2663 2668.
20. Kahlig K. M. Galli A. (2003) Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur. J. Pharmacol. 479, 153 158.
21. Kilic F., Murphy D. Rudnick G. (2003) A Human 5HT Transporter Mutation Causes Constitutive Activation of Transport Activity. (A Human 5HT Transporter Mutation Causes Constitutive Activation of Transport Activity. Mol. Pharmacol. 64, 4 12.
22. Kilic F. Rudnick G. (2000) Oligomerization of 5HT transporter and its functional consequences. Proc. Natl. Acad. Sci. USA 97, 3106 3111.
23. Kocabas A. M., Rudnick G. Kilic F. (2003) Functional consequences of Homo- But Not Hetero-Oligomerization between transporters for the biogenic amine neurotransmitters. J. Neurochem. 85, 1513 1520.
24. Koldzic-Zivanovic N., Seitz P. K., Watson C. S., Cunningham K. A. Thomas M. L. (2004) Intracellular signaling involved in estrogen regulation of serotonin reuptake. Mol. Cell Endocrinol. 226, 33 42.
25. Lesch K. P., Bengel D., Heils A., Sabol S. Z., Greenberg B. D., Petri S., Benjamin J., Muller C. R., Hamer D. H. Murphy D. L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 29, 1527 1531.
26. Lesch K. P., Wolozin B. L., Murphy D. L. Riderer P. (1993) Primary structure of the human platelet 5HT uptake site: identity with the brain 5HT transporter. J. Neurochem. 60, 2319 2322.
27. Lichtman J. H., Krumholz H. M., Wang Y., Radford M. J. Brass L. M. (2002) Risk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular Project. Circulation 5, 1082 1087.
28. Ni W. Watts S. W. (2006) 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin. Exp. Pharmacol. Physiol. 3, 575 583.
29. Ozaki N., Rosenthal N. E., Mazzola P., Chiueh C. C., Hardin T., Garcia-Borreguero D., Schwartz P. J., Turner E., Oren D. A. Murphy D. L. (1994) Platelet [3H]paroxetine binding, 5-HT-stimulated Ca2+ response, and 5-HT content in winter seasonal affective disorder. Biol. Psychiatry 36, 458 466.
30. Ozaslan D., Wang S., Ahmed B., Bene A., Kocabas A. M. Kilic F. (2003) Glycosyl Modification Facilitates Homo- and Hetero-Oligomerization of Serotonin Transporter. A Specific Role for the Sialic Acid Residues. J. Biol. Chem. 278, 43991 44000.
31. Pettinger W., Sheppard H., Palkoski Z. Renyi E. (1973) Angiotensin antagonism and antihypertensive activity of phosphodiesterase inhibiting agents. Life Sci. I. 15, 49 62.
32. Pidgeon G. P., Tamosiuniene R., Chen G., Leonard I., Belton O., Bradford A. Fitzgerald D. J. (2004) Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2. Circulation 26, 2701 2707.
33. Quick M. W. (2003) Regulating the conducting states of a mammalian serotonin transporter. Neuron 40, 537 549.
34. Ramamoorthy S., Cool D. R., Mahesh V. B., Leibach F. H., Melikian H. E., Blakely R. D. Ganapathy V. (1993a) Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J. Biol. Chem. 268, 21626 21631.
35. Ramamoorthy S., Baumen A. L., Moore K. R., Han H., Yang-Fen T., Chang A. S., Ganapathy V. Blakely R. D. (1993b) Antidepressant- and cocaine-sensitive human the 5HT transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 90, 2542 2546.
36. Ramamoorthy S. Blakely R. D. (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285, 763 766.
37. Reis F., Tavares P., Rito L. C., Teixeira H. M., Santos Dias J. D., Ferrer-Antunes C., Mesquita J. F. Teixeira F. (2000) Platelet activation is increased in cyclosporin A-induced hypertensive rats. J. Cardiovasc. Pharmacol. 36, 56 64.
38. Serebruany V. L., Gurbel P. A. O'Connor C. M. (2001) Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol. Res. 43, 453 461.
39. Shulman N. B., Ford C. E., Hall W. D., Blaufox M. D., Simon D., Langford H. G. Schneider K. A. (1989) Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 180 193.
40. Stoddard M. F., Singh P., Dawn B. Longaker R. A. (2003) Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am. Heart J. 145, 676 682.
41. Towbin H., Staehelin T. Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350 4354.
42. Yildiz O., Cicek S., Ay I., Demirkilic U. Tuncer M. (1996) Hypertension increases the contractions to sumatriptan in the human internal mammary artery. Ann. Thorac. Surg. 62, 1392 1396.
43. Yildiz O., Smith J. R. Purdy R. E. (1998) Serotonin and vasoconstrictor synergism. Life Sci. 62, 1723 1732.
44. Watts S. (2005) 5-HT in systemic hypertension. Clin. Sci. 108, 399 412.
45. Willerson J. T. (1995) Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products. Tex Heart Inst. J. 22, 13 19.
46. Woittiez A. J., Wenting G. J., van den Meiracker A. H., Ritsema van Eck H. J., Man in't Veld A. J., Zantvoort F. A. Schalekamp M. A. (1986) Chronic effect of ketanserin in mild to moderate essential hypertension. Hypertension 8, 167 173.
47. Wocial B., Wasowska-Ciszek T., Lapinski M., Januszewicz A., Grzesiuk W., Stepniakowski K. Januszewicz W. (1990) Free serotonin level in the blood of patients with borderline and essential hypertension. Kardiol. Pol. 33, 4 7.
48. Wuller S., Wiesner B., Loffler A., Furkert J., Krause G., Hermosilla R., Schaefer M., Schulein R., Rosenthal W. Oksche A. (2004) Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors. J. Biol. Chem. 279, 47254 47263.